Literature DB >> 27146357

Identification of an IGSF1-specific deletion in a five-generation pedigree with X-linked Central Hypothyroidism without macroorchidism.

James N Hughes1,2, Matthew Aubert1, Jessica Heatlie1, Alison Gardner3, Jozef Gecz2,3, Thomas Morgan4, Joseph Belsky5,6, Paul Q Thomas7,8.   

Abstract

OBJECTIVES: IGSF1 deficiency syndrome (IDS) is a recently described X-linked congenital central hypothyroidism disorder characterized by loss-of-function mutations in the immunoglobulin superfamily member 1 (IGSF1) gene. The phenotypic spectrum and intrafamilial variability associated with IDS remain unclear due to a paucity of large, well-characterized pedigrees. Here, we present phenotypic analysis and molecular characterization of a five-generation pedigree with IGSF1 deficiency containing 10 affected males. PATIENTS AND METHODS: Pituitary function was assessed in all available family members (n = 8 affected males and n = 5 carrier females). Molecular characterization of the family was performed by Sanger sequencing of PCR products amplified from the IGSF1 locus and by array comparative genomic hybridization.
RESULTS: A 42-kb IGSF1 deletion spanning the entire coding sequence was identified in all affected males. TSH deficiency, although subclinical in one case, was identified in all affected males (n = 8). PRL and GH deficiency were also present in 5 of 6 and 4 of 8 affected males, respectively. In contrast to previous reports, macroorchidism was not detected in any of the four affected males who were examined for this feature. Only 1 of 5 carrier females had pituitary dysfunction (TSH and GH deficiency).
CONCLUSION: Individuals with identical IGSF1 deletions can exhibit variable pituitary hormone deficiencies, of which overt TSH deficiency is the most consistent feature. We also show that macroorchidism is not obligatory in males with IDS. Mutations of IGSF1 should therefore be considered in males with isolated hypopituitarism that includes TSH deficiency.
© 2016 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27146357     DOI: 10.1111/cen.13094

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  13 in total

1.  TRH Action Is Impaired in Pituitaries of Male IGSF1-Deficient Mice.

Authors:  Marc-Olivier Turgeon; Tanya L Silander; Denica Doycheva; Xiao-Hui Liao; Marc Rigden; Luisina Ongaro; Xiang Zhou; Sjoerd D Joustra; Jan M Wit; Mike G Wade; Heike Heuer; Samuel Refetoff; Daniel J Bernard
Journal:  Endocrinology       Date:  2017-04-01       Impact factor: 4.736

Review 2.  Central hypothyroidism - a neglected thyroid disorder.

Authors:  Paolo Beck-Peccoz; Giulia Rodari; Claudia Giavoli; Andrea Lania
Journal:  Nat Rev Endocrinol       Date:  2017-05-26       Impact factor: 43.330

3.  The extant immunoglobulin superfamily, member 1 gene results from an ancestral gene duplication in eutherian mammals.

Authors:  Courtney L Smith; Paul M Harrison; Daniel J Bernard
Journal:  PLoS One       Date:  2022-06-02       Impact factor: 3.752

Review 4.  Genetics of Combined Pituitary Hormone Deficiency: Roadmap into the Genome Era.

Authors:  Qing Fang; Akima S George; Michelle L Brinkmeier; Amanda H Mortensen; Peter Gergics; Leonard Y M Cheung; Alexandre Z Daly; Adnan Ajmal; María Ines Pérez Millán; A Bilge Ozel; Jacob O Kitzman; Ryan E Mills; Jun Z Li; Sally A Camper
Journal:  Endocr Rev       Date:  2016-11-09       Impact factor: 19.871

5.  The short mRNA isoform of the immunoglobulin superfamily, member 1 gene encodes an intracellular glycoprotein.

Authors:  Ying Wang; Emilie Brûlé; Tanya Silander; Beata Bak; Sjoerd D Joustra; Daniel J Bernard
Journal:  PLoS One       Date:  2017-07-07       Impact factor: 3.240

6.  The syndrome of central hypothyroidism and macroorchidism: IGSF1 controls TRHR and FSHB expression by differential modulation of pituitary TGFβ and Activin pathways.

Authors:  Marta García; Raquel Barrio; Montserrat García-Lavandeira; Angela R Garcia-Rendueles; Adela Escudero; Esther Díaz-Rodríguez; Darya Gorbenko Del Blanco; Ana Fernández; Yolanda B de Rijke; Elena Vallespín; Julián Nevado; Pablo Lapunzina; Vilborg Matre; Patricia M Hinkle; Anita C S Hokken-Koelega; María P de Miguel; José Manuel Cameselle-Teijeiro; Manuel Nistal; Clara V Alvarez; José C Moreno
Journal:  Sci Rep       Date:  2017-03-06       Impact factor: 4.379

Review 7.  From Consternation to Revelation: Discovery of a Role for IGSF1 in Pituitary Control of Thyroid Function.

Authors:  Daniel J Bernard; Emilie Brûlé; Courtney L Smith; Sjoerd D Joustra; Jan M Wit
Journal:  J Endocr Soc       Date:  2018-02-06

8.  Two siblings with congenital central hypothyroidism caused by a novel mutation in the IGSF1 gene.

Authors:  Makiko Oguma; Mizuki Kobayashi; Masayo Yamazaki; Koji Yokoyama; Shuntaro Morikawa; Takeshi Yamaguchi; Takanori Yamagata; Toshihiro Tajima
Journal:  Clin Pediatr Endocrinol       Date:  2018-04-13

9.  Hypoprolactinemia as a Clue to Diagnosis of Mild Central Hypothyroidism due to IGSF1 Deficiency

Authors:  Anastasios Papadimitriou; Anna Papadopoulou; Kleanthis Kleanthous; Dimitrios T. Papadimitriou; Vassiliki Papaevangelou
Journal:  J Clin Res Pediatr Endocrinol       Date:  2019-08-26

10.  A novel IGSF1 mutation in a large Irish kindred highlights the need for familial screening in the IGSF1 deficiency syndrome.

Authors:  Edna F Roche; Anne McGowan; Olympia Koulouri; Marc-Olivier Turgeon; Adeline K Nicholas; Emmeline Heffernan; Ranna El-Khairi; Noina Abid; Greta Lyons; David Halsall; Marco Bonomi; Luca Persani; Mehul T Dattani; Mark Gurnell; Daniel J Bernard; Nadia Schoenmakers
Journal:  Clin Endocrinol (Oxf)       Date:  2018-10-01       Impact factor: 3.478

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.